This website is intended to inform and educate medical professionals. It is NOT intended for patients, and does not seek to make claims about the effectiveness of regenerative medicine and its respective therapies in medical treatment.
Genova Biologix products are produced in an FDA-compliant laboratory. The FDA has not approved any stem cell-based products for treatment effectiveness other than cord blood-derived hematopoietic progenitor cells for certain indications.
By clicking YES you confirm that you are a medical professional and have read and understood this disclaimer.
What We Do
Regenerative therapy has the potential to transform healthcare through non-invasive procedures — and has made its way into clinical practice due to recent advances in biomedical science. Instead of targeting symptoms, regenerative therapy attempts to restore the structure and function of damaged tissues and cells from past injuries, chronic conditions, degenerative diseases, and more.
Genova Biologix advances this mission with next-generation umbilical cord allograft products — developed to the highest standards of purity, safety, and clinical performance for physicians across every medical specialty.
What We Offer
Research
As further applications of regenerative therapies are studied, the rapidly growing area of research may potentially provide benefits for a variety of diseases and health conditions — from orthopedics and arthritis to diabetes, lupus, heart disease, and more.
View All Research Studies →Partner With Us
Genova Biologix works alongside clinicians and healthcare institutions worldwide, providing education, support, and access to our premium regenerative product line — so you can deliver better outcomes for your patients.
Get In Touch